Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human HEXA ELISA Kit (AC3504)
Cat.#: ASET-2093
Specifications
Description Human HEXA ELISA Kit allows for the in vitro quantitative determination of human HEXA concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.938 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.563-100 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2074 Porcine Luteinizing Hormone ELISA Kit (AC3485) Quantitative inquiry ASET-1164 Human SATB2 ELISA Kit (AC2575) Quantitative inquiry ASET-2480 Human WFS1 ELISA Kit (AC3891) Quantitative inquiry ASET-2434 Human GAB2 ELISA Kit (AC3845) Quantitative inquiry ASET-2225 Rat CART ELISA Kit (AC3636) Quantitative inquiry ASET-1288 Human Somatostatin Receptor 2 ELISA Kit (AC2699) Quantitative inquiry ASET-1446 Human Semaphorin 7a ELISA Kit (AC2857) Quantitative inquiry ASET-2205 Human alpha Synuclein ELISA Kit (AC3616) Quantitative inquiry ASET-1684 Human BMAL1 ELISA Kit (AC3095) Quantitative inquiry ASET-1805 Mouse Adenosine A1 Receptor ELISA Kit (AC3216) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket